A Randomized Phase III Trial of Every-3-Weeks Paclitaxel Versus Dose Dense Weekly Paclitaxel in Combination with Carboplatin With or Without Concurrent and Consolidation Bevacizumab (NSC #704865, IND #7921) in the Treatment of Primary Stage III or IV Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer

Grant

Date/time Interval

  • January 1, 2012 - February 28, 2014
  • Total Award Amount

  • 16200.00
  • Direct Costs

  • 12857.00
  • Sponsor Award Id

  • 6695
  • Contributor

  • Huh M.D., Warner   Investigator  
  • Weber, Therese   Principal Investigator